Provided by Tiger Fintech (Singapore) Pte. Ltd.

PEGBIO CO-B

48.000
+1.6803.63%
Volume:342.00K
Turnover:16.16M
Market Cap:18.53B
PE:-56.84
High:48.260
Open:46.320
Low:46.000
Close:46.320
52wk High:48.260
52wk Low:8.680
Shares:386.00M
HK Float Shares:279.16M
Volume Ratio:0.64
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.844
ROE:-224.15%
ROA:-61.30%
PB:66.39
PE(LYR):-56.84
PS:-4372.61

Loading ...

Company Profile

Company Name:
PEGBIO CO-B
Exchange:
SEHK
Establishment Date:
2008
Employees:
53
Office Location:
Room 606,Building 1,Haozhang Tower,Gongshu District,Hangzhou,Zhejiang Province,China
Zip Code:
215123
Fax:
86 512 6295 6130
Introduction:
PegBio Co Ltd is a China-based company primarily engaged in the discovery and development of innovative therapies. The Company's main product PB-119, is a self-developed, near-commercialized, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309. The Company's products are mainly used to treat chronic and metabolic diseases, including type 2 diabetes mellitus (T2DM, also known as type 2 diabetes), obesity, non-alcoholic steatohepatitis (NASH), opioid-induced constipation (OIC, a gastrointestinal disorder induced by the usage of opioid drugs) and congenital hyperinsulinemia (a rare endocrine disease whose patients experience constant hypoglycemia).

Directors

Name
Position
Michael MIN XU
Chairman of the Board,Executive Director,Chairman of the Strategic and Development Committee,Member of the Nomination Committee
WANG Xiao Jun
Executive Director,Member of the Remuneration and Assessment Committee
ZHANG JIANCUN
Independent Director,Chairman of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
CHEN Yang Yang
Independent Director,Member of the Audit Committee
FAN Xin Peng
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee
ZHOU Xiangjun
Director,Member of the Strategic and Development Committee,Member of the Audit Committee
XU Yu Hong
Director,Member of the Strategic and Development Committee
DI Ting
Director
LI Hong Kai
Director
WANG Meng Jiao
Supervisor,Employee Supervisor
KONG Yong Jun
Supervisory
LI Dong
Supervisory

Shareholders

Name
Position
Michael MIN XU
General Manager
WANG Xiao Jun
CFO
HUANG Yi Feng
Board Secretary,Corporate Secretary,Other Senior Executives
ZOU Xing Long
Corporate Secretary